10.25384/SAGE.7343366.v1 Yuksel Urun Yuksel Urun H Arzu Yasar H Arzu Yasar Hande Turna Hande Turna Ece Esin Ece Esin A Murat Sedef A Murat Sedef Ali Alkan Ali Alkan Berna Oksuzoglu Berna Oksuzoglu Nuriye Ozdemir Nuriye Ozdemir MA Nahit Sendur MA Nahit Sendur Ahmet Sezer Ahmet Sezer Saadettin Kılıckap Saadettin Kılıckap Gungor Utkan Gungor Utkan Tulay Akman Tulay Akman Hakan Akbulut Hakan Akbulut Ismail Celik Ismail Celik Huseyin Abalı Huseyin Abalı Supplemental material for Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study SAGE Journals 2018 Ipilimumab melanoma prognostic factors absolute lymphocytes count 2018-11-06 12:00:00 Journal contribution https://sage.figshare.com/articles/journal_contribution/Supplemental_material_for_Prognostic_factors_for_survival_in_patients_with_metastatic_malign_melanoma_treated_with_ipilimumab_Turkish_Oncology_Group_study/7343366 <p>Supplemental material for Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study by Yuksel Urun, H Arzu Yasar, Hande Turna, Ece Esin, A Murat Sedef, Ali Alkan, Berna Oksuzoglu, Nuriye Ozdemir, MA Nahit Sendur, Ahmet Sezer, Saadettin Kılıckap, Gungor Utkan, Tulay Akman, Hakan Akbulut, Ismail Celik and Huseyin Abalı in Journal of Oncology Pharmacy Practice</p>